Skip to main content
. 2020 Sep 18;61(6):993–998. doi: 10.1093/jrr/rraa092

Table 4.

Clinical results of studies using different isodose prescription

Author/publication year n PIL Operable Tumor size Dose 3 Year LCa 3 YearOSa Grade ≥2 pulmonary toxicity
<3/≥ 3 cm (in 5 fractions)
Takeda et al. [2] 2009 63 80% 14 (22%) 38/25 50 Gy 93% 73% 5%
Tsurugai et al. [3] 2019 250b 60% 66 (28%) 160/90 60 Gy (n = 66) 99% 78% 9.6%
50 Gy (n = 157)
40 Gy (n = 27)

aLC = Local control, OS = overall survival.

b250 Tumors in 237 patients.